Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/IL/Champaign
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Champaign, IL

Studies commonly pay $75 to $4,500 per completed study

176 clinical trials are currently recruiting participants within 30 miles of Champaign. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

176studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Champaign right now

Top 25 of 176 recruiting studies, sorted by proximity — each links to its official registry page

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma Phase 3 Interventional 1,273 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi) · Sponsor: SWOG Cancer Research Network

The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials

Cancer N/A Interventional 500 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi) · Sponsor: Eastern Cooperative Oncology Group

WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis Phase 2 Interventional 164 participants sought
WISPer site in Champaign, IL — Champaign, Illinois (1.6 mi) · Sponsor: Mediar Therapeutics

Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program

Cigarette Smoking-Related Carcinoma Phase 3 Interventional 600 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Multiple conditions N/A Observational 2,900 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma Phase 3 Interventional 880 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi) · Sponsor: NRG Oncology

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum N/A Interventional 9,500 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi) · Sponsor: NRG Oncology

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 Phase 3 Interventional 1,875 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi) · Sponsor: National Cancer Institute (NCI)

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

Triple Negative Breast Cancer Phase 3 Interventional 1,514 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi) · Sponsor: Gilead Sciences

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Multiple conditions Phase 2 Interventional 98 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi) · Sponsor: NRG Oncology

Non-Invasive Neurofeedback Training to Alleviate Tinnitus Distress

Tinnitus Aggravated, Tinnitus N/A Interventional 20 participants sought
Beckman Institute Biomedical Imaging Centre — Urbana, Illinois (3.5 mi) · Sponsor: University of Illinois at Urbana-Champaign

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

Breast Neoplasms, Brain Neoplasms Phase 1, Phase 2 Interventional 73 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi) · Sponsor: Stemline Therapeutics, Inc.

Fall Prevention Among People With Spinal Cord Injury and Multiple Sclerosis Who Use Wheelchairs and Scooters

Spinal Cord Injuries (SCI), Multiple Sclerosis N/A Interventional 120 participants sought
Disability Participation and Quality of Life (DPQOL) Laboratory — Urbana, Illinois (3.5 mi) · Sponsor: University of Illinois at Urbana-Champaign

Alcohol, Breast Cancer, and Metabolism

Alcohol Drinking, Ethanol Intoxication N/A Interventional 50 participants sought
Bevier Hall; University of Illinois at Urbana Champaign — Urbana, Illinois (3.5 mi) · Sponsor: University of Illinois at Urbana-Champaign

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi) · Sponsor: SWOG Cancer Research Network

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma Phase 3 Interventional 1,295 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Breast Cancer, Locally Advanced Breast Cancer Phase 3 Interventional 1,000 participants sought
Clinical Trial Site — Urbana, Illinois (3.5 mi) · Sponsor: Olema Pharmaceuticals, Inc.

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

Renal Pelvis and Ureter Urothelial Carcinoma Phase 2, Phase 3 Interventional 131 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi) · Sponsor: National Cancer Institute (NCI)

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Breast Cancer, Metastatic Breast Cancer Phase 3 Interventional 404 participants sought
Carle Foundation Cancer Institute-Urbana — Urbana, Illinois (3.5 mi) · Sponsor: BriaCell Therapeutics Corporation

Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis Phase 2 Interventional 165 participants sought
Christie Clinic on University /ID# 277871 — Champaign, Illinois (1.6 mi) · Sponsor: AbbVie

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Obesity or Overweight, Weight-Related Comorbidity Phase 3 Interventional 500 participants sought
Research Site — Champaign, Illinois (1.6 mi) · Sponsor: AstraZeneca

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 2,400 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi) · Sponsor: SWOG Cancer Research Network

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Relapsing Multiple Sclerosis, Multiple Sclerosis N/A Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Urbana, Illinois (3.5 mi) · Sponsor: TG Therapeutics, Inc.

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma Phase 3 Interventional 336 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi) · Sponsor: National Cancer Institute (NCI)
Actively enrolling

Studies you may be able to join near Champaign

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Champaign

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Cline Center for Advanced Social Research

★ 3.7
2001 S 1st St Ste 207, Champaign, IL 61820
(217) 265-7845

Christie Clinic Clinical Research

1801 W Windsor Rd, Champaign, IL 61822
(217) 366-2200

Alcohol Research Lab

Psychology Building, 603 E Daniel St Room 23, Champaign, IL 61820
(217) 300-5850

Coordinated Science Laboratory

★ 4.6
1308 W Main St Rm B16, Urbana, IL 61801
(217) 333-2511
"Lots of offices and an auditorium."
— Dave Vesely, 4★

U of I Urbana-Champaign Cancer Center at Illinois

Beckman Institute for Advanced Science and Technology, 405 N Mathews Ave, Urbana, IL 61801
(217) 300-6100

University of Illinois Counseling Center

★ 2.4 (18 reviews)
610 E John St Rm 206, Champaign, IL 61820
(217) 333-3704
"Absurd contract they try to get you to sign which puts everything against the student seeking help. They pretend to not know any better. Ludicrous."
— John B, 1★

Carle Cancer Institute Urbana

★ 4.3
509 W University Ave, Urbana, IL 61801
(217) 383-3010

Christie Clinic Department of Dermatology- Cosmetic Center

★ 4.3
101 W University Ave, Champaign, IL 61820
(217) 366-1248

Carle Neuroscience Institute

★ 3.5
610 N Lincoln Ave, Urbana, IL 61801
(217) 383-6555
"It's clean, and seemed quiet. I had a great doctor that listened to me. The front desk staff seemed respectful."
— Samantha Ragazincky, 5★

Clinical trials in Champaign: what's recruiting

The Champaign area currently has 176 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Champaign, the most active research areas are:

  • Cancer & Oncology17 studies
  • Lungs & Breathing2 studies
  • Liver & Kidney2 studies
  • Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Champaign, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Champaign

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Champaign participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Champaign?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Champaign?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Champaign?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Champaign.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Champaign typically complete one or two studies per year.

Paid clinical trials near Champaign

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of IL

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts